Income Statement Toei Company, Ltd.

Equities

9605

JP3560000006

Entertainment Production

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-05-21 am EDT			5-day change	1st Jan Change
5,620.00 ^JPY	-2.94%		-4.58%	+2.93%

Mar. 17	Toei Company, Ltd. Provides Special Dividend Guidance for the Fiscal Year Ending March 31, 2026	CI
Feb. 19	Toei Company to Change Consolidated Subsidiary Name	MT

21e6d.ZEGxZd5Fakt_jA-9Q6l7nr92AvlRruY00YOui8IrPsw.LXbHI4R3ADg41UCOJsA8ydcSZM1g3LVZ_ODeufpaC_8VHsMTlRUCHhL2Xg

Published financial data: TOEI COMPANY, LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	108B	118B	174B	171B	180B
Total Revenues	108B	118B	174B	171B	180B
Cost of Goods Sold, Total	67.75B	70.55B	103B	104B	105B
Gross Profit	39.9B	46.99B	71.45B	66.89B	75.29B
Selling General & Admin Expenses, Total	25.37B	27.76B	33.54B	37.51B	40.01B
Provision for Bad Debts	3M	16M	15M	44M	128M
Depreciation & Amortization - (IS)	1.53B	1.4B	1.56B	-	-
Other Operating Expenses, Total	26.9B	29.18B	35.11B	37.55B	40.14B
Operating Income	13B	17.81B	36.34B	29.34B	35.16B
Interest Expense, Total	-108M	-66M	-115M	-87M	-139M
Interest And Investment Income	872M	1.12B	1.65B	1.83B	2.13B
Net Interest Expenses	764M	1.05B	1.54B	1.74B	1.99B
Income (Loss) On Equity Invest.	4.21B	3.15B	1.89B	2.12B	3.58B
Currency Exchange Gains (Loss)	-	-	-429M	1.9B	-787M
Other Non Operating Income (Expenses)	858M	1.29B	836M	237M	53M
EBT, Excl. Unusual Items	18.83B	23.3B	40.17B	35.34B	39.99B
Gain (Loss) On Sale Of Investments	109M	-364M	2M	430M	-130M
Gain (Loss) On Sale Of Assets	-119M	718M	-	-22M	-
Asset Writedown	-545M	-1.15B	-1.54B	-279M	-261M
Other Unusual Items	-470M	-226M	-18M	-57M	-290M
EBT, Incl. Unusual Items	17.81B	22.28B	38.61B	35.41B	39.31B
Income Tax Expense	5.15B	5.93B	11.58B	10.32B	10.12B
Earnings From Continuing Operations	12.66B	16.34B	27.03B	25.09B	29.19B
Net Income to Company	12.66B	16.34B	27.03B	25.09B	29.19B
Minority Interest	-5.37B	-7.37B	-12B	-11.12B	-13.47B
Net Income - (IS)	7.28B	8.98B	15.02B	13.97B	15.72B
Net Income to Common Incl Extra Items	7.28B	8.98B	15.02B	13.97B	15.72B
Net Income to Common Excl. Extra Items	7.28B	8.98B	15.02B	13.97B	15.72B
Per Share Items
Net EPS - Basic	116.75	144.66	242.5	225.67	253.95
Basic EPS - Continuing Operations	116.75	144.66	242.5	225.67	253.95
Basic Weighted Average Shares Outstanding	62.39M	62.06M	61.96M	61.91M	61.91M
Net EPS - Diluted	116.75	144.66	242.5	225.67	253.95
Diluted EPS - Continuing Operations	116.75	144.66	242.5	225.67	253.95
Diluted Weighted Average Shares Outstanding	62.39M	62.06M	61.96M	61.91M	61.91M
Normalized Basic EPS	102.55	115.97	211.48	177.1	186.21
Normalized Diluted EPS	102.55	115.97	211.48	177.1	186.21
Dividend Per Share	12	12	12	12	12
Payout Ratio	12.38	8.61	5.14	11.99	11.06
Supplemental Items
EBITDA	16.6B	21.3B	39.76B	33.01B	39.49B
EBITA	13B	17.81B	36.34B	29.34B	35.16B
EBIT	13B	17.81B	36.34B	29.34B	35.16B
EBITDAR	19.28B	24.24B	42.98B	36.28B	42.87B
Effective Tax Rate - (Ratio)	28.93	26.63	30	29.13	25.75
Normalized Net Income	6.4B	7.2B	13.1B	10.96B	11.53B
Non-Cash Pension Expense	-91M	-261M	-164M	-182M	-443M
Supplemental Operating Expense Items
Advertising Expense	1.22B	2.12B	3.39B	4.21B	4.31B
Selling and Marketing Expenses	1.22B	2.12B	3.39B	4.21B	4.31B
Net Rental Expense, Total	2.69B	2.94B	3.22B	3.27B	3.38B
Imputed Operating Lease Interest Expense	162M	85.08M	177M	153M	238M
Imputed Operating Lease Depreciation	2.52B	2.85B	3.04B	3.12B	3.14B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	68.52B	81.63B	93.61B	105B	105B
Total Cash And Short Term Investments	68.52B	81.63B	93.61B	105B	105B
Accounts Receivable, Total	20.12B	23.71B	37.89B	38.85B	43.71B
Total Receivables	20.12B	23.71B	37.89B	38.85B	43.71B
Inventory	13.39B	19.64B	18.76B	17.33B	15.82B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	4.55B	4.5B	4.96B	8.3B	5.87B
Total Current Assets	107B	129B	155B	170B	171B
Net Property Plant And Equipment	89.33B	89.26B	90.39B	91.58B	98.02B
Long-term Investments	126B	128B	132B	148B	192B
Other Intangibles, Total	1.13B	1.09B	1.78B	1.97B	2.05B
Loans Receivable Long-Term	513M	412M	339M	261M	208M
Deferred Tax Assets Long-Term	236M	202M	327M	274M	795M
Other Long-Term Assets, Total	1M	1M	2M	1M	2M
Total Assets	324B	349B	380B	411B	464B
Liabilities
Accounts Payable, Total	19.8B	28.57B	32.23B	33.54B	33.36B
Accrued Expenses, Total	1.14B	1.18B	1.4B	1.44B	1.64B
Short-term Borrowings	9.3B	7.57B	350M	240M	200M
Current Portion of Long-Term Debt	2.44B	3.13B	1.23B	1.21B	7.28B
Current Income Taxes Payable	3.42B	3.2B	7.38B	3.63B	5.9B
Other Current Liabilities	10.65B	12B	14.96B	13.88B	13.48B
Total Current Liabilities	46.75B	55.65B	57.54B	53.93B	61.87B
Long-Term Debt	6.8B	7.22B	13.99B	12.78B	9.93B
Pension & Other Post Retirement Benefits	7.9B	5.67B	5.18B	4.93B	4.54B
Deferred Tax Liability Non Current	7.97B	7.97B	7.94B	15.52B	23.35B
Other Non Current Liabilities	10.66B	10.93B	12.07B	8.02B	9.63B
Total Liabilities	80.06B	87.44B	96.72B	95.18B	109B
Common Stock, Total	11.71B	11.71B	11.71B	11.71B	11.71B
Additional Paid In Capital	22.6B	22.6B	22.66B	22.76B	22.88B
Retained Earnings	134B	142B	157B	169B	183B
Treasury Stock	-11.03B	-11.04B	-11.6B	-11.59B	-11.58B
Comprehensive Income and Other	32.94B	35.04B	33.09B	44.51B	58.59B
Total Common Equity	190B	201B	213B	236B	265B
Minority Interest	53.76B	60.36B	70.55B	79.78B	89.68B
Total Equity	244B	261B	283B	316B	354B
Total Liabilities And Equity	324B	349B	380B	411B	464B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	62.06M	62.06M	61.91M	61.91M	61.91M
ECS Total Common Shares Outstanding	62.06M	62.06M	61.91M	61.91M	61.91M
Book Value / Share	3.07K	3.24K	3.43K	3.82K	4.27K
Tangible Book Value	189B	200B	211B	234B	263B
Tangible Book Value Per Share	3.05K	3.22K	3.41K	3.79K	4.24K
Total Debt	18.54B	17.92B	15.57B	14.23B	17.41B
Net Debt	-49.98B	-63.71B	-78.05B	-90.96B	-88.04B
Debt Equivalent of Unfunded Proj. Benefit Obligation	4.74B	2.72B	2.43B	685M	-684M
Debt Equivalent Oper. Leases	21.49B	23.5B	25.78B	26.16B	27.04B
Minority Interest, Total (Incl. Fin. Div)	53.76B	60.36B	70.55B	79.78B	89.68B
Inventories - Raw Materials, Total	416M	425M	192M	656M	647M
Inventories - Work In Process, Total	11.84B	17.65B	12.5B	14.47B	11.71B
Inventories - Finished Goods, Total	1.14B	1.57B	6.07B	2.21B	3.46B
Full Time Employees	1.04K	1.05K	1.06K	1.1K	1.76K
Accumulated Allowance for Doubtful Accounts (Supple)	78M	62M	58M	90M	177M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	17.81B	22.28B	38.61B	35.41B	39.31B
Depreciation & Amortization - CF	3.6B	3.49B	3.42B	3.66B	4.33B
Depreciation & Amortization, Total	3.6B	3.49B	3.42B	3.66B	4.33B
(Gain) Loss From Sale Of Asset	545M	436M	1.54B	279M	261M
(Gain) Loss on Sale of Investments - (CF)	-109M	364M	-2M	-427M	166M
(Income) Loss On Equity Investments - (CF)	-4.21B	-3.15B	-1.89B	-2.12B	-3.58B
Other Operating Activities, Total	-5.08B	-4.26B	-5.33B	-12.27B	-7.66B
Change In Accounts Receivable	-1.2B	-2.67B	-13.59B	-293M	-3.76B
Change In Inventories	-2.31B	-7.4B	914M	1.44B	1.54B
Change In Accounts Payable	-873M	8.46B	3.52B	-900M	-1.09B
Change in Other Net Operating Assets	-6.4B	-3.07B	123M	-2.71B	4.13B
Cash from Operations	1.77B	14.48B	27.32B	22.08B	33.65B
Capital Expenditure	-3.36B	-7.32B	-4.5B	-4.35B	-8.28B
Sale of Property, Plant, and Equipment	-	4B	-	-	-
Sale (Purchase) of Intangible assets	-362M	-348M	-1.03B	-741M	-747M
Investment in Marketable and Equity Securities, Total	-4.25B	-14.54B	-2.02B	-3.92B	-7.68B
Net (Increase) Decrease in Loans Originated / Sold - Investing	148M	210M	2M	82M	54M
Other Investing Activities, Total	21M	136M	-266M	-871M	-815M
Cash from Investing	-7.8B	-17.86B	-7.82B	-9.8B	-17.47B
Short Term Debt Issued, Total	9.1B	-	-	-	-
Long-Term Debt Issued, Total	4.3B	4B	8.5B	-	4.5B
Total Debt Issued	13.4B	4B	8.5B	-	4.5B
Short Term Debt Repaid, Total	-	-1.73B	-7.22B	-110M	-40M
Long-Term Debt Repaid, Total	-4.97B	-2.89B	-3.63B	-1.23B	-1.28B
Total Debt Repaid	-4.97B	-4.62B	-10.85B	-1.34B	-1.32B
Issuance of Common Stock	-	-	-	9M	-
Repurchase of Common Stock	-4M	-10M	-557M	-5M	-2M
Common Dividends Paid	-902M	-773M	-773M	-1.68B	-1.74B
Common & Preferred Stock Dividends Paid	-902M	-773M	-773M	-1.68B	-1.74B
Other Financing Activities, Total	-2.08B	-2B	-2.92B	-4.53B	-6.06B
Cash from Financing	5.44B	-3.4B	-6.6B	-7.54B	-4.62B
Foreign Exchange Rate Adjustments	276M	809M	1.02B	1.88B	-501M
Miscellaneous Cash Flow Adjustments	1M	1M	-2M	-	-1M
Net Change in Cash	-316M	-5.97B	13.92B	6.61B	11.06B
Supplemental Items
Cash Interest Paid	109M	64M	110M	87M	135M
Cash Income Tax Paid (Refund)	6.3B	6.23B	7.06B	13.41B	8.84B
Levered Free Cash Flow	-4.09B	7.07B	17.79B	10.5B	18.17B
Unlevered Free Cash Flow	-4.03B	7.11B	17.86B	10.56B	18.26B
Change In Net Working Capital	12.03B	-146M	2.74B	6.35B	-980M
Net Debt Issued / Repaid	8.43B	-619M	-2.35B	-1.34B	3.18B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.6	3.31	6.24	4.64	5.02
Return on Total Capital	3.28	4.11	7.86	5.83	6.26
Return On Equity %	5.42	6.47	9.93	8.37	8.71
Return on Common Equity	4	4.59	7.27	6.22	6.28
Margin Analysis
Gross Profit Margin %	37.06	39.98	40.98	39.04	41.85
SG&A Margin	23.56	23.62	19.24	21.89	22.24
EBITDA Margin %	15.42	18.13	22.8	19.26	21.95
EBITA Margin %	12.07	15.15	20.84	17.12	19.54
EBIT Margin %	12.07	15.15	20.84	17.12	19.54
Income From Continuing Operations Margin %	11.76	13.91	15.5	14.64	16.22
Net Income Margin %	6.77	7.64	8.62	8.15	8.74
Net Avail. For Common Margin %	6.77	7.64	8.62	8.15	8.74
Normalized Net Income Margin	5.94	6.12	7.52	6.4	6.41
Levered Free Cash Flow Margin	-3.8	6.01	10.2	6.13	10.1
Unlevered Free Cash Flow Margin	-3.74	6.05	10.24	6.16	10.15
Asset Turnover
Asset Turnover	0.34	0.35	0.48	0.43	0.41
Fixed Assets Turnover	1.2	1.32	1.94	1.88	1.9
Receivables Turnover (Average Receivables)	5.52	5.36	5.66	4.47	4.36
Inventory Turnover (Average Inventory)	5.54	4.27	5.36	5.79	6.31
Short Term Liquidity
Current Ratio	2.28	2.33	2.7	3.15	2.76
Quick Ratio	1.9	1.89	2.29	2.67	2.41
Operating Cash Flow to Current Liabilities	0.04	0.26	0.47	0.41	0.54
Days Sales Outstanding (Average Receivables)	66.17	68.05	64.48	81.96	83.74
Days Outstanding Inventory (Average Inventory)	65.94	85.46	68.1	63.23	57.83
Average Days Payable Outstanding	105.23	114.92	108.75	116.81	118.4
Cash Conversion Cycle (Average Days)	26.89	38.59	23.83	28.38	23.17
Long Term Solvency
Total Debt/Equity	7.59	6.86	5.5	4.5	4.91
Total Debt / Total Capital	7.06	6.42	5.21	4.3	4.68
LT Debt/Equity	2.78	2.76	4.94	4.04	2.8
Long-Term Debt / Total Capital	2.59	2.59	4.68	3.87	2.67
Total Liabilities / Total Assets	24.7	25.08	25.46	23.13	23.58
EBIT / Interest Expense	120.35	269.86	315.99	337.28	252.92
EBITDA / Interest Expense	153.66	322.8	345.74	379.4	284.07
(EBITDA - Capex) / Interest Expense	122.58	211.95	306.63	329.37	224.53
Total Debt / EBITDA	1.12	0.84	0.39	0.43	0.44
Net Debt / EBITDA	-3.01	-2.99	-1.96	-2.76	-2.23
Total Debt / (EBITDA - Capex)	1.4	1.28	0.44	0.5	0.56
Net Debt / (EBITDA - Capex)	-3.77	-4.55	-2.21	-3.17	-2.82
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-23.86	9.19	48.34	-1.73	5.01
Gross Profit, 1 Yr. Growth %	-22.17	17.78	52.06	-6.38	12.56
EBITDA, 1 Yr. Growth %	-35.05	28.38	86.62	-16.98	19.63
EBITA, 1 Yr. Growth %	-40.93	37.03	104.03	-19.25	19.81
EBIT, 1 Yr. Growth %	-40.93	37.03	104.03	-19.25	19.81
Earnings From Cont. Operations, 1 Yr. Growth %	-31.41	29.13	65.37	-7.16	16.32
Net Income, 1 Yr. Growth %	-35.86	23.24	67.37	-7.02	12.53
Normalized Net Income, 1 Yr. Growth %	-26.9	12.48	82.07	-16.33	5.15
Diluted EPS Before Extra, 1 Yr. Growth %	-35.34	23.91	67.63	-6.94	12.53
Accounts Receivable, 1 Yr. Growth %	6.34	17.88	59.79	2.53	12.51
Inventory, 1 Yr. Growth %	20.81	46.67	-4.52	-7.6	-8.71
Net Property, Plant and Equip., 1 Yr. Growth %	-0.52	-0.07	1.26	1.32	7.04
Total Assets, 1 Yr. Growth %	7.93	7.52	8.99	8.3	12.7
Tangible Book Value, 1 Yr. Growth %	9.5	5.51	5.59	11.21	11.99
Common Equity, 1 Yr. Growth %	9.46	5.46	5.91	11.21	11.92
Cash From Operations, 1 Yr. Growth %	-92.53	719.41	88.71	-19.2	52.41
Capital Expenditures, 1 Yr. Growth %	-17.42	118	-38.52	-3.22	90.12
Levered Free Cash Flow, 1 Yr. Growth %	-127.21	-272.58	151.72	-40.94	72.99
Unlevered Free Cash Flow, 1 Yr. Growth %	-126.66	-276.49	151.27	-40.88	72.92
Dividend Per Share, 1 Yr. Growth %	0	0	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-11.37	-8.82	27.27	20.74	1.58
Gross Profit, 2 Yr. CAGR %	-11.61	-4.25	33.83	19.31	2.65
EBITDA, 2 Yr. CAGR %	-20.52	-8.69	54.79	24.47	-0.35
EBITA, 2 Yr. CAGR %	-24.78	-10.03	67.2	28.35	-1.64
EBIT, 2 Yr. CAGR %	-24.78	-10.03	67.2	28.35	-1.64
Earnings From Cont. Operations, 2 Yr. CAGR %	-15.89	-5.89	46.13	23.91	3.92
Net Income, 2 Yr. CAGR %	-17.94	-11.09	43.62	24.75	2.29
Normalized Net Income, 2 Yr. CAGR %	-16.44	-9.32	43.11	23.43	-6.2
Diluted EPS Before Extra, 2 Yr. CAGR %	-17.47	-10.49	44.12	24.9	2.33
Accounts Receivable, 2 Yr. CAGR %	-8.42	11.96	37.25	28	7.4
Inventory, 2 Yr. CAGR %	15.05	33.12	18.34	-6.07	-8.16
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.45	-0.3	0.59	1.29	4.14
Total Assets, 2 Yr. CAGR %	4.6	7.72	8.25	8.64	10.47
Tangible Book Value, 2 Yr. CAGR %	5.95	7.49	5.55	8.36	11.6
Common Equity, 2 Yr. CAGR %	5.93	7.44	5.68	8.52	11.56
Cash From Operations, 2 Yr. CAGR %	-70.31	-21.79	293.23	23.48	10.97
Capital Expenditures, 2 Yr. CAGR %	16.47	34.17	15.77	-22.86	35.64
Levered Free Cash Flow, 2 Yr. CAGR %	-48.63	-31.48	108.42	21.92	1.08
Unlevered Free Cash Flow, 2 Yr. CAGR %	-49.15	-31.4	110.59	21.88	1.11
Dividend Per Share, 2 Yr. CAGR %	0	0	0	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-4.69	-4.99	7.24	16.76	15.25
Gross Profit, 3 Yr. CAGR %	-3.67	-2.73	11.71	18.8	17.02
EBITDA, 3 Yr. CAGR %	-7.09	-6.75	15.88	25.76	22.83
EBITA, 3 Yr. CAGR %	-9.38	-8.13	18.2	31.18	25.44
EBIT, 3 Yr. CAGR %	-9.38	-8.13	18.2	31.18	25.44
Earnings From Cont. Operations, 3 Yr. CAGR %	-7.15	-2.97	13.56	25.62	21.32
Net Income, 3 Yr. CAGR %	-12.06	-6.02	9.78	24.25	20.54
Normalized Net Income, 3 Yr. CAGR %	-8.28	-7.74	14.4	19.66	17.01
Diluted EPS Before Extra, 3 Yr. CAGR %	-11.72	-5.5	10.33	24.57	20.63
Accounts Receivable, 3 Yr. CAGR %	4.48	-0.38	26.06	24.53	22.61
Inventory, 3 Yr. CAGR %	21.2	24.75	19.16	8.97	-6.96
Net Property, Plant and Equip., 3 Yr. CAGR %	-0.42	-0.32	0.22	0.83	3.17
Total Assets, 3 Yr. CAGR %	5.83	5.56	8.14	8.26	9.98
Tangible Book Value, 3 Yr. CAGR %	6.6	5.8	6.85	7.41	9.56
Common Equity, 3 Yr. CAGR %	6.54	5.77	6.93	7.49	9.65
Cash From Operations, 3 Yr. CAGR %	-51.82	-10.28	4.9	132.04	32.45
Capital Expenditures, 3 Yr. CAGR %	-30.62	43.54	3.44	9.06	4.2
Levered Free Cash Flow, 3 Yr. CAGR %	18.58	-23.07	5.73	36.9	37
Unlevered Free Cash Flow, 3 Yr. CAGR %	16.39	-23.01	5.75	37.89	36.96
Dividend Per Share, 3 Yr. CAGR %	0	0	0	0	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-2.6	-1.75	7	4.57	4.94
Gross Profit, 5 Yr. CAGR %	-0.9	0.91	9.87	5.55	7.99
EBITDA, 5 Yr. CAGR %	-2.91	0.95	13.96	4.67	9.1
EBITA, 5 Yr. CAGR %	-4.12	0.69	15.78	5.02	9.82
EBIT, 5 Yr. CAGR %	-4.12	0.69	15.78	5.02	9.82
Earnings From Cont. Operations, 5 Yr. CAGR %	0.79	0.58	11.32	7	9.6
Net Income, 5 Yr. CAGR %	-3.46	-3.91	7.01	5.25	6.72
Normalized Net Income, 5 Yr. CAGR %	-4.76	-1.11	9.58	3.65	5.66
Diluted EPS Before Extra, 5 Yr. CAGR %	-3.23	-3.58	7.4	5.66	7.06
Accounts Receivable, 5 Yr. CAGR %	6.82	5.96	16.53	10.12	18.23
Inventory, 5 Yr. CAGR %	13.91	24.31	20.05	11.37	7.37
Net Property, Plant and Equip., 5 Yr. CAGR %	1.35	1.12	-0.02	0.32	1.77
Total Assets, 5 Yr. CAGR %	6.2	6.23	6.79	6.78	9.07
Tangible Book Value, 5 Yr. CAGR %	7.5	6.65	6.18	6.82	8.73
Common Equity, 5 Yr. CAGR %	7.46	6.6	6.2	6.86	8.76
Cash From Operations, 5 Yr. CAGR %	-36.68	-2.02	11.58	1.94	7.29
Capital Expenditures, 5 Yr. CAGR %	2.95	18.84	-14.85	11.96	15.29
Levered Free Cash Flow, 5 Yr. CAGR %	-19.44	-9.64	48.59	-7.51	3.84
Unlevered Free Cash Flow, 5 Yr. CAGR %	-19.92	-9.75	47.55	-7.48	3.87
Dividend Per Share, 5 Yr. CAGR %	0	0	0	0	0